{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infant+and+Young+Children&page=3", "query": { "condition": "Infant and Young Children", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 57, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infant+and+Young+Children&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infant+and+Young+Children&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T15:16:09.362Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00179998", "title": "Effectiveness of Pulmozyme in Infants With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "Recombinant Human DNase (Pulmozyme)", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nationwide Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "30 Months", "sex": "ALL", "summary": "1 Month to 30 Months" }, "enrollment_count": 24, "start_date": "2005-01", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2019-05-09", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00179998" }, { "nct_id": "NCT02167217", "title": "Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Duchenne Muscular Dystrophy" ], "interventions": [ { "name": "Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "30 Months", "sex": "MALE", "summary": "1 Month to 30 Months · Male only" }, "enrollment_count": 25, "start_date": "2014-04-17", "completion_date": "2017-03-22", "has_results": true, "last_update_posted_date": "2018-12-21", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 6, "location_summary": "Sacramento, California • Orlando, Florida • Chicago, Illinois + 3 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02167217" }, { "nct_id": "NCT01205152", "title": "Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypophosphatasia" ], "interventions": [ { "name": "asfotase alfa", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "24 Weeks", "maximum_age": "42 Months", "sex": "ALL", "summary": "24 Weeks to 42 Months" }, "enrollment_count": 10, "start_date": "2009-04", "completion_date": "2016-08", "has_results": true, "last_update_posted_date": "2019-03-13", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 5, "location_summary": "Wilmington, Delaware • Springfield, Missouri • Omaha, Nebraska + 2 more", "locations": [ { "city": "Wilmington", "state": "Delaware" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Green Bay", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01205152" }, { "nct_id": "NCT07261254", "title": "Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Income", "Infant, Newborn", "Mothers", "Poverty", "United States", "Healthcare Disparities", "Child Care", "Child Health", "Community Health Workers", "Hispanic or Latino", "Medicaid", "Child Development", "Social Services Utilization", "Health Services Utilization" ], "interventions": [ { "name": "Community Health Worker", "type": "BEHAVIORAL" }, { "name": "Community Health Worker + Guaranteed Basic Income", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Days", "maximum_age": null, "sex": "ALL", "summary": "0 Days and older" }, "enrollment_count": 2400, "start_date": "2025-04-07", "completion_date": "2030-03", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07261254" }, { "nct_id": "NCT00880100", "title": "Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis", "Pancreatic Insufficiency" ], "interventions": [ { "name": "Ultrase® MT12", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "2 Years to 6 Years" }, "enrollment_count": 49, "start_date": "2009-04", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2017-03-16", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 15, "location_summary": "Aurora, Colorado • Ann Arbor, Michigan • Grand Rapids, Michigan + 11 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Syracuse", "state": "New York" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00880100" }, { "nct_id": "NCT05455671", "title": "Real-Time Assessment of Lung Structure and Function in Children and Young Adults With CF Using Electrical Impedance Tomography", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cystic Fibrosis", "Healthy" ], "interventions": [], "intervention_types": [], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "3 Years to 21 Years" }, "enrollment_count": 48, "start_date": "2022-08-01", "completion_date": "2024-08-20", "has_results": false, "last_update_posted_date": "2025-11-13", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05455671" }, { "nct_id": "NCT03083444", "title": "P Gingivalis Oral Infection, Intimamedia Thickening in Infants, Atherosclerosis", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Tooth Eruption, Atherosclerosis" ], "interventions": [ { "name": "Ultrasound", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Creighton University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "4 Months to 24 Months" }, "enrollment_count": 0, "start_date": "2017-04-15", "completion_date": "2018-11-30", "has_results": false, "last_update_posted_date": "2018-01-25", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03083444" }, { "nct_id": "NCT05535166", "title": "Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Medulloblastoma" ], "interventions": [ { "name": "Surgical resection", "type": "PROCEDURE" }, { "name": "Ommaya/VPS", "type": "PROCEDURE" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Topotecan", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Pegfilgrastim", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" }, { "name": "Irradiation", "type": "RADIATION" }, { "name": "Educational and Media Intervention", "type": "OTHER" }, { "name": "SOC, Educational and Media Intervention", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "RADIATION", "OTHER" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "59 Months", "sex": "ALL", "summary": "Up to 59 Months" }, "enrollment_count": 130, "start_date": "2022-12-20", "completion_date": "2035-07", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 10, "location_summary": "Palo Alto, California • Orlando, Florida • Tampa, Florida + 7 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05535166" }, { "nct_id": "NCT05796570", "title": "A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Myelodysplastic Syndromes", "Myeloid Malignancies", "MDS", "Inherited Bone Marrow Failure Syndrome", "Myeloid Neoplasm", "Aml" ], "interventions": [ { "name": "Decitabine", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Franziska Wachter", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "39 Years", "sex": "ALL", "summary": "1 Year to 39 Years" }, "enrollment_count": 29, "start_date": "2023-04-19", "completion_date": "2029-09-01", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05796570" }, { "nct_id": "NCT05086016", "title": "Growth Trial: Study of the Renata Minima Stent", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coarctation of the Aorta", "Pulmonary Artery Stenosis" ], "interventions": [ { "name": "Catheterized Stenting", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Renata Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 42, "start_date": "2021-01-14", "completion_date": "2028-03-30", "has_results": true, "last_update_posted_date": "2025-03-25", "last_synced_at": "2026-10-04T15:16:09.362Z", "location_count": 7, "location_summary": "Los Angeles, California • Boston, Massachusetts • Cincinnati, Ohio + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05086016" } ] }